β-Adrenergic agonist medications such as albuterol are the mainstay for treatment of patients with acute asthma exacerbations. Patients who present to the emergency department with severe symptoms are often treated with multiple albuterol doses in sequence to maximize the impact of the medications, relax bronchoconstriction, and relieve their breathlessness. Patients who present with acute dyspnea have numerous potential causes of hyperlactatemia and acidosis including an uncommonly recognized outcome of albuterol administration. This clinical case report outlines a scenario where a patient who was treated for an acute asthma exacerbation had rising lactate levels despite improving clinically. Causes of elevated lactate levels are discussed, particularly related to β-adrenergic agonist use, and considerations for monitoring and withdrawal of albuterol administration are outlined.
Skip Nav Destination
Article navigation
Fall 2024
Symposium: Case Reports in Critical Care|
September 15 2024
β-Adrenergic Agonist–Induced Lactic Acidosis: A Case Report
Raymond R. Blush, III, DNP, ACNP-BC
Raymond R. Blush, III, DNP, ACNP-BC
Raymond R. Blush III is Clinical Assistant Professor, University of Michigan School of Nursing, Room 2304, 400 SNB N Ingalls, Ann Arbor, MI 48109 ([email protected]).
Search for other works by this author on:
AACN Adv Crit Care (2024) 35 (3): 222–227.
Citation
Raymond R. Blush; β-Adrenergic Agonist–Induced Lactic Acidosis: A Case Report. AACN Adv Crit Care 15 September 2024; 35 (3): 222–227. doi: https://doi.org/10.4037/aacnacc2024787
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access
65
Views